These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 19038868)

  • 1. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
    Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
    Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
    Touyz RM; Callera GE
    Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
    [No Abstract]   [Full Text] [Related]  

  • 3. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
    Deliyanti D; Miller AG; Tan G; Binger KJ; Samson AL; Wilkinson-Berka JL
    Hypertension; 2012 Mar; 59(3):607-13. PubMed ID: 22275532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
    Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
    Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
    Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
    World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II and aldosterone activate retinal microglia.
    Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
    Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.
    Wei Y; Whaley-Connell AT; Habibi J; Rehmer J; Rehmer N; Patel K; Hayden M; DeMarco V; Ferrario CM; Ibdah JA; Sowers JR
    Hypertension; 2009 Feb; 53(2):158-65. PubMed ID: 19114643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
    Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
    Hatzopoulos KM; Vessey KA; Wilkinson-Berka JL; Fletcher EL
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3957-70. PubMed ID: 24894399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.
    Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
    Glia; 2008 Aug; 56(10):1076-90. PubMed ID: 18442090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb.
    Kobayashi N; Fukushima H; Takeshima H; Koguchi W; Mamada Y; Hirata H; Machida Y; Suzuki N; Yokotsuka F; Tabei K; Kobayashi E; Fukuda N; Ishimitsu T
    Am J Hypertens; 2010 Sep; 23(9):1007-13. PubMed ID: 20431528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
    Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
    Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
    Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.